Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […]
SAN FRANCISCO, May 28, 2024 Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for.
Olema Oncology Announces Promising New Data for globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
These Are the Most Heavily Shorted Stocks Heating Up the Market 247wallst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 247wallst.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.